Three-dimensional tumor spheroid assays further demonstrated enhanced tissue penetration, decreased TGF-β1 expression, and notable tumor inhibition, underscoring nintedanib’s role in stromal remodeling. The gene discussed is TGFB1; the disease is neoplasm.